north america cardiac assist devices market outlook to 2020north america cardiac assist devices...

North America Cardiac Assist Devices Market Outlook to 2020 GDMECR0089DB / Published May 2014

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form

North America Cardiac Assist Devices

Market Outlook to 2020

Reference Code: GDMECR0089DB

Publication Date: May 2014



1 Table of Contents

1 Table of Contents .................................................................................................................................................... 2

1.1 List of Tables .................................................................................................................................................... 5

1.2 List of Figures ................................................................................................................................................... 6

2 Introduction .............................................................................................................................................................. 8

2.1 What Is This Report About? ............................................................................................................................. 8

2.2 Cardiac Assist Devices Market Segmentation ................................................................................................. 8

2.3 Definitions of Markets Covered in the Report .................................................................................................. 9

3 Cardiac Assist Devices Market, North America ................................................................................................. 11

3.1 Cardiac Assist Devices Market, North America, Revenue ($m), 2005-2020 ................................................. 11

3.2 Cardiac Assist Devices Market, North America, Category Comparison by Revenue ($m), 2005-2020 ........ 13



3.5 Cardiac Assist Devices Market, North America, Volume (Units), 2005-2020 ................................................ 19



3.8 Cardiac Assist Devices Market, North America, Company Share by Revenue ($m), 2011-2012 ................. 25

4 Cardiac Assist Devices Market, Canada ............................................................................................................. 27

4.1 Cardiac Assist Devices Market, Canada, Revenue ($m), 2005-2012 ........................................................... 27

4.2 Cardiac Assist Devices Market, Canada, Revenue ($m), 2012-2020 ........................................................... 29

4.2.1 Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), by Segment, 2005-2012 ............................ 31

4.2.2 Ventricular Assist Devices Market, Canada, Revenue ($m), by Segment, 2005-2012 ............................. 33

4.2.3 Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), by Segment, 2012-2020 ............................ 35

4.2.4 Ventricular Assist Devices Market, Canada, Revenue ($m), by Segment, 2012-2020 ............................. 37

4.3 Cardiac Assist Devices Market, Canada, Volume (Units), 2005-2012 .......................................................... 39

4.4 Cardiac Assist Devices Market, Canada, Volume (Units), 2012-2020 .......................................................... 41

4.4.1 Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), by Segment, 2005-2012 ........................... 43

4.4.2 Ventricular Assist Devices Market, Canada, Volume (Units), by Segment, 2005-2012 ............................ 45

4.4.3 Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), by Segment, 2012-2020 ........................... 47

4.4.4 Ventricular Assist Devices Market, Canada, Volume (Units), by Segment, 2012-2020 ............................ 49

4.5 Cardiac Assist Devices Market, Canada, Average Price ($), 2005-2020 ...................................................... 51

4.6 Cardiac Assist Devices Market, Canada, Distribution Share by Revenue ($m), 2011-2012 ......................... 53

4.7 Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), 2011-2012 ........................... 54

5 Cardiac Assist Devices Market, Mexico .............................................................................................................. 56

5.1 Cardiac Assist Devices Market, Mexico, Revenue ($m), 2005-2012 ............................................................. 56

5.2 Cardiac Assist Devices Market, Mexico, Revenue ($m), 2012-2020 ............................................................. 58

5.2.1 Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), by Segment, 2005-2012 ............................. 60

5.2.2 Ventricular Assist Devices Market, Mexico, Revenue ($m), by Segment, 2005-2012 .............................. 62

5.2.3 Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), by Segment, 2012-2020 ............................. 64

5.2.4 Ventricular Assist Devices Market, Mexico, Revenue ($m), by Segment, 2012-2020 .............................. 66



5.3 Cardiac Assist Devices Market, Mexico, Volume (Units), 2005-2012 ............................................................ 68

5.4 Cardiac Assist Devices Market, Mexico, Volume (Units), 2012-2020 ............................................................ 70

5.4.1 Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), by Segment, 2005-2012 ............................ 72

5.4.2 Ventricular Assist Devices Market, Mexico, Volume (Units), by Segment, 2005-2012 ............................. 74

5.4.3 Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), by Segment, 2012-2020 ............................ 76

5.4.4 Ventricular Assist Devices Market, Mexico, Volume (Units), by Segment, 2012-2020 ............................. 78

5.5 Cardiac Assist Devices Market, Mexico, Average Price ($), 2005-2020 ....................................................... 80

5.6 Cardiac Assist Devices Market, Mexico, Distribution Share by Revenue ($m), 2011-2012 .......................... 82

5.7 Cardiac Assist Devices Market, Mexico, Company Share by Revenue ($m), 2011-2012 ............................. 83

6 Cardiac Assist Devices Market, United States ................................................................................................... 85

6.1 Cardiac Assist Devices Market, United States, Revenue ($m), 2005-2012 .................................................. 85

6.2 Cardiac Assist Devices Market, United States, Revenue ($m), 2012-2020 .................................................. 87

6.2.1 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2005-2012 ................... 89

6.2.2 Ventricular Assist Devices Market, United States, Revenue ($m), by Segment, 2005-2012 .................... 91

6.2.3 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2012-2020 ................... 93

6.2.4 Ventricular Assist Devices Market, United States, Revenue ($m), by Segment, 2012-2020 .................... 95

6.3 Cardiac Assist Devices Market, United States, Volume (Units), 2005-2012 ................................................. 97

6.4 Cardiac Assist Devices Market, United States, Volume (Units), 2012-2020 ................................................. 99

6.4.1 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2005-2012 ................ 101

6.4.2 Ventricular Assist Devices Market, United States, Volume (Units), by Segment, 2005-2012 ................. 103

6.4.3 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2012-2020 ................ 105

6.4.4 Ventricular Assist Devices Market, United States, Volume (Units), by Segment, 2012-2020 ................. 107

6.5 Cardiac Assist Devices Market, United States, Average Price ($), 2005-2020 ........................................... 109

6.6 Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 .............. 111

6.7 Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), 2011-2012 ................ 112

7 Overview of Key Companies in North America Cardiac Assist Devices Market .......................................... 114

7.1 Thoratec Corporation ................................................................................................................................... 114

7.1.1 Company Overview .................................................................................................................................. 114

7.2 Maquet Holding B.V. & Co. KG. ................................................................................................................... 114


7.3 HeartWare International, Inc. ....................................................................................................................... 114


7.4 Teleflex Incorporated ................................................................................................................................... 115


7.5 SynCardia Systems, Inc. .............................................................................................................................. 115


7.6 Berlin Heart GmbH ....................................................................................................................................... 115


7.7 Abiomed, Inc. ............................................................................................................................................... 116


8 Cardiac Assist Devices Market Pipeline Products ........................................................................................... 117



9 Recent Developments ......................................................................................................................................... 119

9.1 Corporate Communications ......................................................................................................................... 119

9.1.1 Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director ............................................... 119

9.1.2 Jan 28, 2014: St. Jude Medical Announces Organizational and Executive Leadership Changes .......... 119

9.1.3 Jul 22, 2013: St. Jude Medical Appoints Stefan Widensohler to Its Board of Directors .......................... 120

9.1.4 Jul 03, 2013: Novartis Files Patent Infringement Lawsuit Against Intas Pharma Over Generic Myfortic 120

9.2 Financial Announcements ............................................................................................................................ 121

9.2.1 Apr 16, 2014: St. Jude Medical Reports First Quarter 2014 Results ....................................................... 121

9.2.2 Jan 22, 2014: St. Jude Medical Reports Fourth Quarter and Full-Year 2013 Results ............................ 123

9.2.3 Jan 14, 2014: Aduro Announces Phase 2 Clinical Trial Results Demonstrating Statistically Significant Survival Benefit in Pancreatic Cancer Patients Treated with its Novel Immunotherapies .................................... 125

9.2.4 Dec 09, 2013: St. Jude Medical Announces Fourth Quarter Dividend .................................................... 125

9.2.5 Oct 16, 2013: St. Jude Medical Reports Third Quarter 2013 Results ...................................................... 126

9.2.6 Oct 02, 2013: St. Jude Medical Announces Third Quarter 2013 Earnings Conference Call ................... 128

9.2.7 Jul 30, 2013: Teleflex subsidiary receives 510(k) clearance for balloon dilatation catheters .................. 128

9.2.8 Jul 30, 2013: St. Jude Medical Announces Third Quarter Dividend ........................................................ 129

9.2.9 Jul 17, 2013: St. Jude Medical Reports Second Quarter 2013 Results ................................................... 130

9.2.10 Jul 02, 2013: St. Jude Medical Announces Second Quarter 2013 Earnings Conference Call ............ 131

9.3 Government and Public Interest ................................................................................................................... 132

9.3.1 Dec 18, 2013: St. Jude Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference ... 132

9.3.2 Nov 21, 2013: St. Jude Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference .... 132

9.3.3 Nov 06, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference .............. 132

9.3.4 Nov 01, 2013: St. Jude Medical to Present at the 2013 Credit Suisse Healthcare Conference .............. 132

9.3.5 Sep 04, 2013: St. Jude Medical to Present at the Stifel Healthcare Conference .................................... 132

9.3.6 Sep 03, 2013: St. Jude Medical to Present at the Morgan Stanley Global Healthcare Conference ....... 132

9.4 Legal And Regulatory ................................................................................................................................... 132

9.4.1 Mar 03, 2014: CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts ....................................................................................................... 132

9.5 Other Significant Developments ................................................................................................................... 134

9.5.1 Feb 24, 2014: St. Jude Medical Announces Increase in Quarterly Dividend........................................... 134

9.6 Product News ............................................................................................................................................... 134

9.6.1 Mar 26, 2014: UT Southwestern Medical Center implants first small left ventricular assist device for young patient ......................................................................................................................................................... 134

9.6.2 Dec 27, 2013: Mymetics Enters Into Licensing Agreement With RSV For Respiratory Syncytial Virus Vaccine 135

9.6.3 Oct 03, 2013: Cardiopulmonary Rehab Clinics to Benefit from ScottCare‟s Industry-Exclusive Telemetry Transmitter ............................................................................................................................................................. 138

9.6.4 May 28, 2013: Abiomed Gets Reimbursement Approval For Impella In Netherlands ............................. 138

10 Appendix ........................................................................................................................................................... 139

10.1 Research Methodology ................................................................................................................................ 140

10.1.1 Coverage .............................................................................................................................................. 140

10.1.2 Secondary Research ............................................................................................................................ 140



10.1.3 Primary Research ................................................................................................................................. 141

10.1.4 Market Modeling and Forecasting ........................................................................................................ 142

10.1.5 Company Share Analysis ..................................................................................................................... 145

10.1.6 Distribution Share Analysis .................................................................................................................. 146

10.2 Expert Panel ................................................................................................................................................. 146

10.3 GlobalData Consulting ................................................................................................................................. 147

10.4 Disclaimer ..................................................................................................................................................... 147

1.1 List of Tables

Table 1: Cardiac Assist Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020

......................................................................................................................................................................................................... 12

Table 2: Cardiac Assist Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 ... 14

Table 3: Cardiac Assist Devices Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012 .............................. 16

Table 4: Cardiac Assist Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020 ............................ 18

Table 5: Cardiac Assist Devices Market, North America, Volume (Units), 2005-2020 ................................................................... 20

Table 6: Cardiac Assist Devices Market, North America, Volume (Units), Historic, 2005-2012 ...................................................... 22

Table 7: Cardiac Assist Devices Market, North America, Volume (Units), Forecast, 2012-2020 .................................................... 24

Table 8: Cardiac Assist Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2011-2012 ............ 26

Table 9: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................ 28

Table 10: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 .................................... 30

Table 11: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 32

Table 12: Ventricular Assist Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 ................................. 34

Table 13: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 .............................. 36

Table 14: Ventricular Assist Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................... 38

Table 15: Cardiac Assist Devices Market, Canada, Volume (Units), Historic, 2005-2012 .............................................................. 40

Table 16: Cardiac Assist Devices Market, Canada, Volume (Units), Forecast, 2012-2020 ............................................................ 42

Table 17: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), Historic, 2005-2012 ........................................................ 44

Table 18: Ventricular Assist Devices Market, Canada, Volume (Units), Historic, 2005-2012 ......................................................... 46

Table 19: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), Forecast, 2012-2020 ...................................................... 48

Table 20: Ventricular Assist Devices Market, Canada, Volume (Units), Forecast, 2012-2020 ....................................................... 50

Table 21: Cardiac Assist Devices Market, Canada, Average Price ($), Historic, 2005-2012 .......................................................... 51

Table 22: Cardiac Assist Devices Market, Canada, Average Price ($), Forecast, 2012-2020 ........................................................ 52

Table 23: Cardiac Assist Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................. 53

Table 24: Cardiac Assist Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 .................... 55

Table 25: Cardiac Assist Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 ....................................... 57

Table 26: Cardiac Assist Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 ..................................... 59

Table 27: Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 ................................. 61

Table 28: Ventricular Assist Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012................................... 63

Table 29: Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................... 65

Table 30: Ventricular Assist Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020................................. 67

Table 31: Cardiac Assist Devices Market, Mexico, Volume (Units), Historic, 2005-2012 ............................................................... 69

Table 32: Cardiac Assist Devices Market, Mexico, Volume (Units), Forecast, 2012-2020 ............................................................. 71



Table 33: Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), Historic, 2005-2012 ......................................................... 73

Table 34: Ventricular Assist Devices Market, Mexico, Volume (Units), Historic, 2005-2012 .......................................................... 75

Table 35: Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), Forecast, 2012-2020 ....................................................... 77

Table 36: Ventricular Assist Devices Market, Mexico, Volume (Units), Forecast, 2012-2020 ........................................................ 79

Table 37: Cardiac Assist Devices Market, Mexico, Average Price ($), Historic, 2005-2012 ........................................................... 80

Table 38: Cardiac Assist Devices Market, Mexico, Average Price ($), Forecast, 2012-2020 ......................................................... 81

Table 39: Cardiac Assist Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ................... 82

Table 40: Cardiac Assist Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2011-2012 ...................... 84

Table 41: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ............................. 86

Table 42: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ........................... 88

Table 43: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ....................... 90

Table 44: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ........................ 92

Table 45: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ..................... 94

Table 46: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ...................... 96

Table 47: Cardiac Assist Devices Market, United States, Volume (Units), Historic, 2005-2012 ..................................................... 98

Table 48: Cardiac Assist Devices Market, United States, Volume (Units), Forecast, 2012-2020 ................................................. 100

Table 49: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), Historic, 2005-2012 ............................................. 102

Table 50: Ventricular Assist Devices Market, United States, Volume (Units), Historic, 2005-2012 .............................................. 104

Table 51: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), Forecast, 2012-2020 ........................................... 106

Table 52: Ventricular Assist Devices Market, United States, Volume (Units), Forecast, 2012-2020 ............................................ 108

Table 53: Cardiac Assist Devices Market, United States, Average Price ($), Historic, 2005-2012 ............................................... 109

Table 54: Cardiac Assist Devices Market, United States, Average Price ($), Forecast, 2012-2020 ............................................. 110

Table 55: Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ....... 111

Table 56: Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 ......... 113

Table 57: Cardiac Assist Devices Market Pipeline Products ........................................................................................................ 117

Table 58 Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country ..................................... 142

1.2 List of Figures

Figure 1: Cardiac Assist Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020

......................................................................................................................................................................................................... 11

Figure 2: Cardiac Assist Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 .. 13

Figure 3: Cardiac Assist Devices Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012............................. 15

Figure 4: Cardiac Assist Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020........................... 17

Figure 5: Cardiac Assist Devices Market, North America, Volume (Units), 2005-2020 .................................................................. 19

Figure 6: Cardiac Assist Devices Market, North America, Volume (Units), Historic, 2005-2012 .................................................... 21

Figure 7: Cardiac Assist Devices Market, North America, Volume (Units), Forecast, 2012-2020 .................................................. 23

Figure 8: Cardiac Assist Devices Market, North America, Company Share (%), 2012 ................................................................... 25

Figure 9: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 ....................................... 27

Figure 10: Cardiac Assist Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 ................................... 29

Figure 11: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 ............................... 31

Figure 12: Ventricular Assist Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 33

Figure 13: Intra-Aortic Balloon Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................. 35

Figure 14: Ventricular Assist Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 .............................. 37



Figure 15: Cardiac Assist Devices Market, Canada, Volume (Units), Historic, 2005-2012 ............................................................. 39

Figure 16: Cardiac Assist Devices Market, Canada, Volume (Units), Forecast, 2012-2020 ........................................................... 41

Figure 17: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), Historic, 2005-2012 ....................................................... 43

Figure 18: Ventricular Assist Devices Market, Canada, Volume (Units), Historic, 2005-2012 ........................................................ 45

Figure 19: Intra-Aortic Balloon Pumps Market, Canada, Volume (Units), Forecast, 2012-2020 ..................................................... 47

Figure 20: Ventricular Assist Devices Market, Canada, Volume (Units), Forecast, 2012-2020 ...................................................... 49

Figure 21: Cardiac Assist Devices Market, Canada, Company Share (%), 2012 ........................................................................... 54

Figure 22: Cardiac Assist Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 ...................................... 56

Figure 23: Cardiac Assist Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 .................................... 58

Figure 24: Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 60

Figure 25: Ventricular Assist Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 ................................. 62

Figure 26: Intra-Aortic Balloon Pumps Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 .............................. 64

Figure 27: Ventricular Assist Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................... 66

Figure 28: Cardiac Assist Devices Market, Mexico, Volume (Units), Historic, 2005-2012 .............................................................. 68

Figure 29: Cardiac Assist Devices Market, Mexico, Volume (Units), Forecast, 2012-2020 ............................................................ 70

Figure 30: Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), Historic, 2005-2012 ........................................................ 72

Figure 31: Ventricular Assist Devices Market, Mexico, Volume (Units), Historic, 2005-2012 ......................................................... 74

Figure 32: Intra-Aortic Balloon Pumps Market, Mexico, Volume (Units), Forecast, 2012-2020 ...................................................... 76

Figure 33: Ventricular Assist Devices Market, Mexico, Volume (Units), Forecast, 2012-2020 ....................................................... 78

Figure 34: Cardiac Assist Devices Market, Mexico, Company Share (%), 2012 ............................................................................ 83

Figure 35: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ............................ 85

Figure 36: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .......................... 87

Figure 37: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ...................... 89

Figure 38: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 ....................... 91

Figure 39: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 .................... 93

Figure 40: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 ..................... 95

Figure 41: Cardiac Assist Devices Market, United States, Volume (Units), Historic, 2005-2012 .................................................... 97

Figure 42: Cardiac Assist Devices Market, United States, Volume (Units), Forecast, 2012-2020 .................................................. 99

Figure 43: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), Historic, 2005-2012 ............................................ 101

Figure 44: Ventricular Assist Devices Market, United States, Volume (Units), Historic, 2005-2012 ............................................. 103

Figure 45: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), Forecast, 2012-2020 .......................................... 105

Figure 46: Ventricular Assist Devices Market, United States, Volume (Units), Forecast, 2012-2020 ........................................... 107

Figure 47: Cardiac Assist Devices Market, United States, Company Share (%), 2012 ................................................................ 112

Figure 48: GlobalData Epidemiology-Based Forecasting Model .................................................................................................. 144

Figure 49: GlobalData Capital Equipment-Based Forecasting Model .......................................................................................... 145

Figure 50: Primary Interviews by Participant Type (%) ................................................................................................................. 146



2 Introduction

Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms

of revenues, unit sales, distributors and competitors.

2.1 What Is This Report About?

This report provides an overview and the following information related to the country, various categories, distribution

share and competitive landscape in the market:

1. Comprehensive data related to the market revenue, unit sale, average price, company share and

distribution share.

2. Corporate-level profiles of key companies operating in the Cardiac Assist Devices market, which includes

a brief overview of the company. The selection of the companies is based on their operational presence.

3. A list of key products under development by different companies. The selection of this list is based on the

territory in which these products are being clinically investigated.

4. Key news and deals related to the Cardiac Assist Devices market.

2.2 Cardiac Assist Devices Market Segmentation

Cardiac Assist Devices market is segmented as described below, in this report:

1. Intra-Aortic Balloon Pumps

• Intra-Aortic Balloon Pumps includes sub-segments such as Intra-Aortic Balloon Pump Catheters and

Intra-Aortic Balloon Pump Consoles

2. Total Artificial Heart

3. Ventricular Assist Devices

• Ventricular Assist Devices includes sub-segments such as Biventricular Assist Devices, External

Ventricular Assist Devices, Left Ventricular Assist Devices and Right Ventricular Assist Devices



2.3 Definitions of Markets Covered in the Report

Cardiac Assist Devices

Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy.

These devices can be used for both short term and long term purposes allowing the heart to rest long enough so that

it can return to normal. Cardiac assist devices include Total Artificial Heart (TAH) devices, Ventricular Assist Devices

(VAD) and Intra-Aortic Balloon Pumps (IABP).

Total Artificial Heart

A total artificial heart is a prosthetic device that is implanted into the body to replace the biological heart. One unit

refers to one total artificial heart.

Ventricular Assist Devices

A Ventricular Assist Device (VAD) is a mechanical pump that helps a heart that is too weak to pump blood through

the body. It is sometimes referred to as “a bridge to transplant” since it can help a patient survive until a heart

transplant can be performed.

Left Ventricular Assist Devices

A left ventricular assist device is a ventricular assist system intended for the treatment of advanced-stage heart

failure. It assists the left ventricle in pumping the blood. One unit refers to one left ventricular assist device with

accessories.

Right Ventricular Assist Devices

A right ventricular assist device is a ventricular assist system intended to assist the right ventricle in pumping the

blood. One unit refers to one right ventricular assist device with accessories.

External Ventricular Assist Devices

An external ventricular assist device is provided for augmenting cardiac contractions. This is connected surgically to

an EKG machine which actuates a fluid pump in response to the QRS waves of the heart. It consists of a flexible,

non-distensible shell adapted to be positioned over the heart base. One unit refers to one external ventricular assist

device with accessories.

Biventricular Assist Devices

Biventricular Assist device is a ventricular assist system intended to assist both the ventricles in pumping the blood.

One unit refers to one biventricular assist device with accessories.



Intra-Aortic Balloon Pumps

The Intra-aortic balloon pump (IABP) is a mechanical device that is used to decrease myocardial oxygen demand

while at the same time increasing cardiac output. By increasing cardiac output it also increases coronary blood flow

and therefore myocardial oxygen delivery. It consists of a cylindrical balloon that sits in the aorta and counter

pulsates.

Intra-Aortic Balloon Pump Catheters

Intra-Aortic Balloon Catheters are catheters used in conjunction with Intra-Aortic Balloon Pumps to assist in improving

the cardiac output to meet the oxygen demand of the body. One unit refers to one Intra-Aortic Balloon Pump

Catheter.

Intra-Aortic Balloon Pump Consoles

Intra-aortic balloon pump console triggers and optimizes counter pulsation support to patients. The console triggers

the counter pulsatisation based on factors like ECG readings or pressure required. These systems automatically sets

both the inflate and deflate timings. It comes along in a cart with a monitor and an internal battery. One unit refers to

one intra-aortic balloon pump console with all the above mentioned components.



3 Cardiac Assist Devices Market, North America

3.1 Cardiac Assist Devices Market, North America, Revenue ($m), 2005-2020

Figure 1: Cardiac Assist Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant,

2005-2020

Source: GlobalData



Table 1: Cardiac Assist Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-

2020

Country Name 2005 2012 2020 CAGR 05-12 CAGR 12-20 CAGR 05-20

Source: GlobalData



3.2 Cardiac Assist Devices Market, North America, Category Comparison by Revenue ($m), 2005-2020

Figure 2: Cardiac Assist Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-

2020

Source: GlobalData



Table 2: Cardiac Assist Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-

2020

Category 2012 CAGR 05-12 CAGR 12-20

Source: GlobalData



Page 139

10 Appendix

The data and analysis within this report are driven by Medical eTrack. Medical eTrack gives you the key information

required to drive sales, investment and deal-making activity in your business. It includes the following:

15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries,

from 2005 and forecast to 2020

6,000+ primary expert interviews, conducted annually to ensure data and report quality

1,100+ medical equipment conference reports

1,000+ industry-leading reports per annum, covering growing sectors, market trends, investment opportunities

and competitive landscape

600+ analysis reports, covering market and pipeline product analysis, by indication; medical equipment trends

and issues, and investment and M&A trends worth over $3m

50,000+ medical equipment company profiles

2,000+ private, emerging and technology start-up company profiles

4,000+ company profiles of medical equipment manufacturers in China and India

2,000+ company profiles of medical equipment manufacturers in Japan

825+ companies‟ revenue splits and market shares

1,100+ quarterly and annual medical equipment company financials

700+ medical equipment company SWOTs

11,700+ pipeline product profiles

14,000+ marketed product profiles

16,900+ clinical trials

17,000+ trial investigators

18,000+ new product patents

3,700+ reports on companies with products in development

21,500+ reports on deals in the medical equipment industry

1,300+ surgical and diagnostic procedures by therapy area

50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

http://www.medicaletrack.com/ContactUs.aspx?Id=RequestDemo



Page 140

10.1 Research Methodology

GlobalData‟s dedicated research and analysis teams consist of experienced professionals with advanced statistical

expertise and marketing, market research and consulting backgrounds in the medical devices industry.

GlobalData adheres to the codes of practice of the European Pharmaceutical Marketing Research Association

(http://www.ephmra.org/).

All GlobalData databases are continuously updated and revised.

10.1.1 Coverage

The objective of updating GlobalData‟s coverage is to ensure that it represents the most up-to-date vision of the

industry possible.

Changes to the industry taxonomy are built on the basis of extensive research of company, association and

competitor sources.

Company coverage is based on three key factors: revenue; product and media attention; and innovation and market

potential.

The estimated revenue of all major companies, both private and public, are gathered and used to prioritize coverage.

GlobalData aims to cover all major news events and deals in the medical devices industry, updated on a daily basis.

The coverage is further streamlined and strengthened with additional input from GlobalData‟s expert panel.

10.1.2 Secondary Research

The research process begins with extensive secondary research using internal and external sources to gather all

relevant data and information pertaining to a particular market model for a particular country. The secondary research

sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings

Industry trade journals, scientific journals and other technical literature

Association and healthcare organization websites

PubMed, Medscape and other relevant services which compile extensive reviews of clinical literature

Internal proprietary databases

Relevant patent and regulatory databases

National government documents, statistical databases and market reports

Procedure registries

News articles, press releases and web-casts specific to the companies operating in the market



Page 141

10.1.3 Primary Research

GlobalData conducts interviews with industry participants and commentators in order to validate its data and analysis.

A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape and

future outlook

Helps to validate and strengthen secondary research findings

Further develops the analysis team‟s expertise and market understanding

Primary research involves email correspondence, telephone interviews and face-to-face interviews for each market,

category, segment and sub-segment across a range of geographies.

The participants who typically take part in such a process include, but are not limited to:

o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and

national sales managers

o Distributors, paramedics and representatives from hospital stores, laboratories and pharmacies

o Outside experts: investment bankers, valuation experts and research analysts that specialize in specific

medical equipment markets

o Key opinion leaders: physicians and surgeons that specialize in the therapeutic areas in which the

medical device is used

The market data was validated based on the inputs from 1,771 primary research participants. The primary research

participants included stakeholders from demand side such as the cardiovascular surgeons, as well as participants

from the supply side such as the marketing managers, sales managers and product managers of companies

manufacturing/marketing cardiovascular devices.



Page 142

Table 58 Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

Country Total Number of Primary Research Participants

United States 136

United Kingdom 120

Germany 128

France 153

Italy 121

Spain 134

Brazil 128

China 79

India 173

Russia 89

Japan 88

Australia 122

Canada 111

Mexico 90

South Korea 99

Total 1,771

Source: GlobalData

10.1.4 Market Modeling and Forecasting

GlobalData uses an epidemiology-based treatment flow model and capital equipment-based model to estimate and

forecast market size.

Epidemiology-Based Market Model and Forecasting

The epidemiology-based forecasting model uses epidemiology data gathered from research publications and primary

interviews with physicians to establish the target patient population and treatment flow pattern for individual diseases

and therapies. The data covers prevalence, incidence, diseased population, diagnosed population, and treatment

population.

The market forecast begins with the general population, the size of which varies depending on the indication.

Prevalence is the percentage of the total population that suffers from a particular disease or condition.

Incidence is the number of new cases of a condition, symptom, death or injury that develop during a specific

time period, such as one year.

The diseased population is the population suffering from a particular disease or condition.

The diagnosed population is the population that has been diagnosed with a particular disease or condition,

expressed as a percentage of the prevalence population.

The treatment population is the percentage of the population that has been diagnosed with a particular

disease or condition.



Page 143

Device uptake is the percentage of the treatment population using a particular device, determined based on

the primary responses and the information available in secondary sources.

The epidemiology-based forecasting model for a medical device is used to:

Determine the patient segment using a particular device or procedure

Determine the frequency of usage of a particular device depending on the patient type, which further helps to

determine the absolute unit sales of a device in a year

The market for any medical device is directly proportional to the volume of units sold and the price per unit.

Market size = volumes of units sold X ASP (Average Selling Price)

The volume of units sold is calculated from the number of patients using or that has been implanted with the device.

Data on treatment rate, diagnosis and surgical treatment rate, if unavailable from research publications, is gathered

from interviews with physicians and used to estimate the patient volume for the disease under consideration.

The ASP of a device is mostly gathered from primary and secondary sources. ASP is the price at which a device is

available in a target country to an end-user. For capital equipment, the end-user is typically considered to be the

healthcare setting. For implants and consumables purchased by patients, the end-user is the patient.

Factors such as company share, reimbursement, company type (local/domestic or multinational) are taken into

consideration during ASP analysis, which uses the following sources:

Company websites

Annual reports/industry reports

Press releases



Page 144

Epidemiology-Based Forecasting Model

Capital Equipment-Based Market Model and Forecasting

The capital equipment-based forecasting model is based on the installed base, replacements and new sales of a

specific type of capital equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. The

installed base is calculated from the average number of units per facility. Sales for a particular year are arrived at by

calculating the number of replacement units and new units (additional and first-time purchases). Secondary sources

and interviews with supply-side participants and key opinion leaders from healthcare facilities are used to arrive at

installed base and unit sales for a particular year. The factors typically affecting the forecast growth rates are:

Growth in the number of healthcare facilities

Healthcare spending and government programs and initiatives

Migration from low-end equipment to high-end equipment

Growth in the diagnosed population and treatment population

Figure 48: GlobalData Epidemiology-Based Forecasting Model

Source: GlobalData



Page 145

Capital Equipment-Based Forecasting Model

10.1.5 Company Share Analysis

Company shares are calculated by analyzing a company‟s sales in a particular market. In the case of public

companies, annual reports and regulatory filings, investor presentations, earnings call transcripts and broker reports

are used to determine a company‟s revenue in a particular market and in a particular geography.

In the case of the private companies, company share data is gathered mostly from primary interviews and secondary

sources. Company share analysis is based on primary interviews with:

Supply side (manufacturers)

Procurement side

Distributors

Hospital purchasing groups

Demand side (surgeons/specialists)

Figure 49: GlobalData Capital Equipment-Based Forecasting Model

Source: GlobalData



Page 146

The benefits of this approach are:

High number of respondents to validate and from which to derive accurate company shares

Broad view from the supply, demand, and procurement side

Prevents biased opinions being reproduced

Demand-side interviews with key opinion leaders help to understand their preferences for the devices of

specific companies, strengthening company share estimates

Primary Interviews by Participant Type

Figure 50: Primary Interviews by Participant Type (%)

The final company share data is based on input from the supply side, the procurement side and the demand side, as

well as secondary sources. Please note that market share for companies that are included under the „Others‟

category is not tracked on an individual basis.

10.1.6 Distribution Share Analysis

Distribution share information is gathered using a combination of secondary and primary research. It is supported by

primary interviews because the availability of secondary data is limited in most cases.

10.2 Expert Panel

GlobalData uses a panel of experts to cross-verify its databases and forecasts.

GlobalData‟s expert panel comprises marketing managers, product specialists, international sales managers from

medical device companies, academics from research universities, key opinion leaders from hospitals, consultants

from venture capital funds and distributors/suppliers of medical equipment and supplies.

Historic data and forecasts are relayed to GlobalData‟s expert panel for feedback and adjusted accordingly.

50

25

25

Procurement side Supply side Demand side



Page 147

10.3 GlobalData Consulting

We hope that the data and analysis in this brief will help you to make informed and imaginative business decisions. If

you have further requirements, GlobalData‟s consulting team may be able to help you. GlobalData offers tailor-made

analytical and advisory services to drive your key strategic decisions.

10.4 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,

electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher,

GlobalData.

north america cardiac assist devices market outlook to 2020north america cardiac assist devices...

Documents